nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amyloid PET in pseudotumoral multiple sclerosis
|
Matías-Guiu, Jordi A. |
|
2017 |
15 |
C |
p. 15-17 3 p. |
artikel |
2 |
Are static and functional balance abilities related in individuals with Multiple Sclerosis?
|
Pau, Massimiliano |
|
2017 |
15 |
C |
p. 1-6 6 p. |
artikel |
3 |
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports
|
Forci, Benedetta |
|
2017 |
15 |
C |
p. 24-26 3 p. |
artikel |
4 |
Does vagotomy protect against multiple sclerosis?
|
Sundbøll, Jens |
|
2017 |
15 |
C |
p. 34-36 3 p. |
artikel |
5 |
Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis?
|
Akcali, Aylin |
|
2017 |
15 |
C |
p. 37-41 5 p. |
artikel |
6 |
Incidence of tonic spasms as the initial presentation of pediatric multiple sclerosis in Slovenia
|
Bizjak, Neli |
|
2017 |
15 |
C |
p. 47-48 2 p. |
artikel |
7 |
Investigation of the prognostic value of adipokines in multiple sclerosis
|
Çoban, Arzu |
|
2017 |
15 |
C |
p. 11-14 4 p. |
artikel |
8 |
Is Toxoplasma gondii infection protective against multiple sclerosis risk?
|
Koskderelioglu, Asli |
|
2017 |
15 |
C |
p. 7-10 4 p. |
artikel |
9 |
Membranous nephropathy with Neuromyelitis optica spectrum disorder
|
Li, Xiangling |
|
2017 |
15 |
C |
p. 49-51 3 p. |
artikel |
10 |
Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: “Second International Workshop on Human Endogenous Retroviruses and Disease”, Washington DC, March 13th and 14th 2017
|
Kremer, David |
|
2017 |
15 |
C |
p. 18-23 6 p. |
artikel |
11 |
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation
|
Kaunzner, Ulrike W. |
|
2017 |
15 |
C |
p. 27-33 7 p. |
artikel |
12 |
Susac Syndrome: A differential diagnosis of white matter lesions
|
Marrodan, Mariano |
|
2017 |
15 |
C |
p. 42-46 5 p. |
artikel |
13 |
The ‘Field Hypothesis’: rebound activity after stopping disease-modifying therapies
|
Giovannoni, Gavin |
|
2017 |
15 |
C |
p. A1-A2 nvt p. |
artikel |